Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Short-term Investments (2024 - 2025)

Praxis Precision Medicines (PRAX) has 2 years of Short-term Investments data on record, last reported at $242.0 million in Q4 2025.

  • For Q4 2025, Short-term Investments rose 36.57% year-over-year to $242.0 million; the TTM value through Dec 2025 reached $242.0 million, up 36.57%, while the annual FY2025 figure was $242.0 million, 36.57% up from the prior year.
  • Short-term Investments reached $242.0 million in Q4 2025 per PRAX's latest filing, up from $117.6 million in the prior quarter.
  • Across five years, Short-term Investments topped out at $242.0 million in Q4 2025 and bottomed at $55.4 million in Q1 2024.